Caseware UK (AP4) 2023.0.135 2023.0.135 2023-09-302023-09-3033No description of principal activity2022-10-01false34truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 05165033 2022-10-01 2023-09-30 05165033 2021-10-01 2022-09-30 05165033 2023-09-30 05165033 2022-09-30 05165033 c:Director3 2022-10-01 2023-09-30 05165033 d:PlantMachinery 2022-10-01 2023-09-30 05165033 d:PlantMachinery 2023-09-30 05165033 d:PlantMachinery 2022-09-30 05165033 d:PlantMachinery d:OwnedOrFreeholdAssets 2022-10-01 2023-09-30 05165033 d:FurnitureFittings 2022-10-01 2023-09-30 05165033 d:FurnitureFittings 2023-09-30 05165033 d:FurnitureFittings 2022-09-30 05165033 d:FurnitureFittings d:OwnedOrFreeholdAssets 2022-10-01 2023-09-30 05165033 d:OtherPropertyPlantEquipment 2022-10-01 2023-09-30 05165033 d:OtherPropertyPlantEquipment 2023-09-30 05165033 d:OtherPropertyPlantEquipment 2022-09-30 05165033 d:OtherPropertyPlantEquipment d:OwnedOrFreeholdAssets 2022-10-01 2023-09-30 05165033 d:OwnedOrFreeholdAssets 2022-10-01 2023-09-30 05165033 d:CurrentFinancialInstruments 2023-09-30 05165033 d:CurrentFinancialInstruments 2022-09-30 05165033 d:Non-currentFinancialInstruments 2023-09-30 05165033 d:Non-currentFinancialInstruments 2022-09-30 05165033 d:CurrentFinancialInstruments d:WithinOneYear 2023-09-30 05165033 d:CurrentFinancialInstruments d:WithinOneYear 2022-09-30 05165033 d:Non-currentFinancialInstruments d:AfterOneYear 2023-09-30 05165033 d:Non-currentFinancialInstruments d:AfterOneYear 2022-09-30 05165033 d:ShareCapital 2023-09-30 05165033 d:ShareCapital 2022-09-30 05165033 d:SharePremium 2023-09-30 05165033 d:SharePremium 2022-09-30 05165033 d:RetainedEarningsAccumulatedLosses 2023-09-30 05165033 d:RetainedEarningsAccumulatedLosses 2022-09-30 05165033 c:OrdinaryShareClass1 2022-10-01 2023-09-30 05165033 c:OrdinaryShareClass1 2023-09-30 05165033 c:FRS102 2022-10-01 2023-09-30 05165033 c:AuditExempt-NoAccountantsReport 2022-10-01 2023-09-30 05165033 c:FullAccounts 2022-10-01 2023-09-30 05165033 c:PrivateLimitedCompanyLtd 2022-10-01 2023-09-30 05165033 e:PoundSterling 2022-10-01 2023-09-30 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 05165033









THE BEAUTIFUL BODY COMPANY (UK) LIMITED







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2023

 
THE BEAUTIFUL BODY COMPANY (UK) LIMITED
REGISTERED NUMBER: 05165033

STATEMENT OF FINANCIAL POSITION
AS AT 30 SEPTEMBER 2023

2023
2022
Note
£
£

Fixed assets
  

Tangible Fixed Assets
 4 
435,159
762,420

  
435,159
762,420

Current assets
  

Stocks
  
270,222
150,352

Debtors: amounts falling due within one year
 5 
110,237
115,014

Cash at bank and in hand
 6 
2,052
61,255

  
382,511
326,621

Creditors: amounts falling due within one year
 7 
(8,050,027)
(7,146,098)

Net current liabilities
  
 
 
(7,667,516)
 
 
(6,819,477)

Total assets less current liabilities
  
(7,232,357)
(6,057,057)

Creditors: amounts falling due after more than one year
 8 
(34,000)
(34,000)

  

Net liabilities
  
(7,266,357)
(6,091,057)


Capital and reserves
  

Called up share capital 
 9 
4
4

Share premium account
  
2,499,997
2,499,997

Profit and loss account
  
(9,766,358)
(8,591,058)

  
(7,266,357)
(6,091,057)


Page 1

 
THE BEAUTIFUL BODY COMPANY (UK) LIMITED
REGISTERED NUMBER: 05165033
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 30 SEPTEMBER 2023

The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 19 August 2024.




V Fieldgrass
Director

The notes on pages 3 to 8 form part of these financial statements.

Page 2

 
THE BEAUTIFUL BODY COMPANY (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023

1.


General information

The Beautiful Body Company (UK) Limited is a private company limited by shares registered in England and Wales. The company's registered office address is 103 Hammersmith Road, London, W14 0QH.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

The accounts have been prepared on a going concern basis in the expectation that the company will receive financial support from its directors and shareholders and will continue trading for the foreseeable future.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the company has transferred the significant risks and rewards of ownership to the buyer;
the company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

Page 3

 
THE BEAUTIFUL BODY COMPANY (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023

2.Accounting policies (continued)

 
2.4

Operating leases: the company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

 
2.5

Pensions

Defined contribution pension plan

The company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the statement of financial position. The assets of the plan are held separately from the company in independently administered funds.

 
2.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Plant and machinery
-
over 5 years
Fixtures and fittings
-
over 10 years
Other fixed assets
-
over 10 years

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.7

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

Page 4

 
THE BEAUTIFUL BODY COMPANY (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023

2.Accounting policies (continued)

  
2.8

Debtors

Short term debtors are measured at transaction price, less any impairment.

  
2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours.

 
2.10

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

  
2.11

Financial instruments

The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties.


3.


Employees

The average monthly number of employees, including directors, during the year was 34 (2022 - 33).

Page 5

 
THE BEAUTIFUL BODY COMPANY (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023

4.


Tangible fixed assets





Plant and machinery
Fixtures and fittings
Other fixed assets
Total

£
£
£
£



Cost or valuation


At 1 October 2022
3,343,838
267,044
1,603,152
5,214,034


Additions
89,645
14,064
-
103,709



At 30 September 2023

3,433,483
281,108
1,603,152
5,317,743



Depreciation


At 1 October 2022
2,862,746
131,524
1,457,344
4,451,614


Charge for the year on owned assets
359,289
27,987
43,694
430,970



At 30 September 2023

3,222,035
159,511
1,501,038
4,882,584



Net book value



At 30 September 2023
211,448
121,597
102,114
435,159



At 30 September 2022
481,092
135,520
145,808
762,420

Page 6

 
THE BEAUTIFUL BODY COMPANY (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023

5.


Debtors

2023
2022
£
£


Amounts owed by group undertakings
22,280
-

Other debtors
1,200
-

Prepayments and accrued income
86,757
115,014

110,237
115,014



6.


Cash and cash equivalents

2023
2022
£
£

Cash at bank and in hand
2,052
61,255

2,052
61,255



7.


Creditors: Amounts falling due within one year

2023
2022
£
£

Trade creditors
178,910
214,744

Amounts owed to group undertakings
7,747,721
6,808,816

Other taxation and social security
42,648
59,466

Obligations under finance lease and hire purchase contracts
23,992
32,250

Other creditors
25,378
24,703

Accruals and deferred income
31,378
6,119

8,050,027
7,146,098



8.


Creditors: Amounts falling due after more than one year

2023
2022
£
£

Net obligations under finance leases and hire purchase contracts
34,000
34,000

34,000
34,000


Page 7

 
THE BEAUTIFUL BODY COMPANY (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023

9.


Share capital

2023
2022
£
£
Allotted, called up and fully paid



4 Ordinary shares of £1.00 each
4
4



10.


Related party transactions

As permitted by FRS 102 paragraphs 1.12e and 33.1a, the company has taken advantage of the exemption from disclosing the transactions entered into between two or more members of a group as all subsidary undertakings are wholly-owned by a member of that group.

 
Page 8